Core Viewpoint - Traditional Chinese medicine (TCM) products are increasingly recognized globally, becoming an important representation of China in international relations, supported by strong policy initiatives [1][2]. Policy Guidance - The strategic significance of TCM service trade in the context of globalization was emphasized by various speakers at the forum, highlighting the need for high-quality development to deepen TCM's internationalization and participation in global health governance [2]. - The Ministry of Commerce has recognized 31 national TCM service export bases and introduced 18 specific support policies to enhance TCM service trade, focusing on platform development, talent training, standard formulation, and market expansion [2][3]. Development Initiatives - The Ministry of Commerce plans to formulate new goals and policies for promoting TCM service trade, aligning with national strategies like the Belt and Road Initiative to expand the scale of TCM service trade [3]. - Beijing has established itself as a key area for TCM service trade, with 1,340 TCM medical institutions and three national TCM service export bases by the end of 2024, enhancing international influence and service capabilities [4]. Standardization Efforts - The forum launched a research report on TCM service trade and initiated a group standard for the "Guidelines for International TCM Medical Services," aimed at creating a scientifically recognized standard system for TCM services [5]. - The lack of standardized practices has been a barrier to TCM's internationalization, and the new guidelines are expected to provide a benchmark for TCM medical institutions globally, ensuring safety and efficacy [5]. Digital Transformation - Digitalization is emerging as a new engine for TCM service trade, with remote medical services, online education, and digital platforms facilitating TCM's international outreach [6]. - The aging global population presents challenges, and the integration of TCM with the elderly care economy is seen as a significant opportunity to leverage TCM's unique advantages in preventive care and rehabilitation [6].

Core Viewpoint - Traditional Chinese medicine (TCM) products are increasingly becoming a significant part of China's international presence, supported by strong policy initiatives aimed at enhancing TCM service trade globally [1][2]. Policy Guidance - TCM has demonstrated unique clinical efficacy in areas such as health maintenance and chronic disease management, highlighting its strategic importance in global health [2]. - The Ministry of Commerce has recognized TCM service trade as a vital area for driving new momentum in foreign trade, with 31 national TCM service export bases established and 18 supportive policies introduced [2][3]. Development Measures - In 2021, a notification was issued to support the high-quality development of national TCM service export bases, focusing on improving mechanisms, innovating support policies, and enhancing international cooperation [3]. - The TCM service export bases are essential for promoting TCM-related healthcare, education, research, and cultural services internationally [3]. Regional Experience - Beijing has developed a replicable model for TCM service trade, with 1,340 TCM medical institutions and three national TCM service export bases established by the end of 2024 [4]. Standardization Initiatives - The forum introduced a research report on TCM service trade and launched a group standard for the "Guidelines for International TCM Medical Services," aimed at establishing a recognized standard system for TCM services [5]. - The lack of standardized protocols has been a barrier to TCM's internationalization, and the new guidelines will provide a benchmark for TCM medical institutions globally [5][6]. Digital Transformation - Digitalization is emerging as a key driver for TCM service trade, with remote medical services and online education becoming new avenues for international outreach [6]. - The growth of service trade exports has outpaced goods trade, indicating significant potential for TCM in the medical tourism sector [6]. Collaborative Efforts - High-quality development of TCM service trade requires collaboration among various stakeholders, including government, industry organizations, and enterprises [7]. - Recent agreements between Chinese institutions and international partners aim to facilitate the global implementation of TCM technologies [7]. Future Outlook - With ongoing policy support, digital integration, and innovative cultural dissemination, TCM service trade is poised to become a new growth engine for China's service exports, contributing significantly to global health governance [7].

Core Viewpoint - Traditional Chinese medicine (TCM) products are increasingly recognized globally, becoming an important symbol of China's connection with the international community, supported by strong policy initiatives [1][3]. Policy Guidance - TCM has demonstrated unique clinical efficacy in areas such as health maintenance and chronic disease management, emphasizing its strategic significance in global health [3]. - The Ministry of Commerce has recognized 31 national TCM service export bases and introduced 18 supportive policies to enhance TCM service trade [4]. Development Measures - A notification issued in 2021 outlines 18 specific measures to support the high-quality development of TCM service export bases, focusing on improving the development environment and fostering international cooperation [4]. - Beijing has established itself as a key area for TCM service trade, with 1,340 TCM medical institutions and three national TCM service export bases by the end of 2024 [5]. Standardization and Digitalization - The launch of the "Guidelines for International Medical Services in TCM" aims to create a standardized and internationally recognized TCM service framework, addressing the lack of standards that hinders TCM's internationalization [6]. - Digitalization is becoming a new engine for TCM service trade, with remote medical services and online education enhancing international accessibility [6]. Market Opportunities - The export growth rate of service trade has surpassed that of goods trade, indicating significant potential for TCM in the medical tourism sector [7]. - The integration of TCM with the aging population's needs presents a unique opportunity to develop a health service system tailored to global aging challenges [7]. Collaborative Efforts - A consensus among representatives from government and industry organizations highlights the necessity for collaborative efforts to enhance the quality of TCM service trade [7]. - Recent agreements between Chinese institutions and international partners aim to facilitate the global implementation of TCM technology services [8].

Group 1 - The core viewpoint of the article highlights the collaboration between Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. and JD Health, showcasing traditional Chinese medicine culture on a global stage through an event at Times Square, New York [1][3] - Pien Tze Huang's flagship product has a history of nearly 500 years, and its traditional production techniques have been recognized as a national intangible cultural heritage [3] - The company has conducted 89 basic research projects and 25 clinical trials to clarify the mechanisms and clinical efficacy of traditional Chinese medicine, integrating modern health concepts with traditional practices [3] Group 2 - The event signifies an important step in the international dissemination of traditional Chinese medicine, enhancing global awareness and appreciation of this cultural heritage [1][3] - Pien Tze Huang aims to continue deepening its engagement in the field of traditional Chinese medicine while promoting modernization and internationalization efforts [3] - The company's presence on the world stage not only demonstrates its brand strength but also aims to revitalize traditional Chinese medicine globally [3]

Core Viewpoint - The collaboration between Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. and JD Health marks a significant step in the internationalization of traditional Chinese medicine, enhancing the brand's global presence and recognition [1][2]. Group 1: International Expansion - Pien Tze Huang has been actively expanding its international footprint, recently participating in events like the "2025 (China) Eurasian Commodity Trade Expo" and the "Fourth China-Africa Economic and Trade Expo" to showcase Chinese medicine culture [1][2]. - The company has established a strong reputation in the overseas Chinese community and ranks among the top exporters of traditional Chinese medicine products [1]. Group 2: Product and Market Development - Pien Tze Huang is focusing on integrating traditional Chinese medicine with modern health concepts to attract the Z generation consumer group [2]. - The company is diversifying its product lines into cosmetics, daily chemicals, and health foods, aiming to combine traditional Chinese medicine culture with modern wellness and beauty trends [2]. Group 3: Research and Development - The company is enhancing its research and development capabilities, with plans to advance two new drug projects and 18 ongoing research initiatives in the first half of the year [2]. - Pien Tze Huang aims to modernize and internationalize the traditional Chinese medicine industry, leveraging innovative development strategies to upgrade its brand value [2].

Core Viewpoint - Traditional Chinese medicine (TCM) is becoming an important force in promoting global health, with Tianyao Daren Tang Group actively participating in international cooperation and product innovation to spread TCM benefits beyond borders [1][2]. Group 1: Company Initiatives - Tianyao Daren Tang's flagship product, "Suxiao Jiuxin Wan," was registered as a prescription drug in Russia in 1997, marking it as the first Chinese patent medicine to receive such approval, which set a benchmark for TCM products entering international markets [1]. - Since 2017, Tianyao Daren Tang has established a stable partnership with Russian TCM companies, leading to the registration of various products, including the Dami Wan series and Jing Wan Hong as dietary supplements and cosmetics in Russia [2]. - The company emphasizes not only product export but also the promotion of TCM culture through international exhibitions and academic exchanges, enhancing local understanding and trust in TCM [2]. Group 2: Future Directions - Tianyao Daren Tang aims to deepen cooperation with countries in the Shanghai Cooperation Organization (SCO) in the field of TCM, focusing on clinical research, technology exchange, and mutual recognition of standards to contribute to a global health community [2][3].

Core Viewpoint - Traditional Chinese medicine (TCM) is gaining popularity and recognition at the 2025 Shanghai Cooperation Organization (SCO) Summit, showcasing its potential as a bridge for health and cultural exchange among SCO member countries [3][5]. Group 1: TCM Promotion and Impact - The TCM therapy point at the SCO Summit is providing services such as pulse diagnosis and massage, attracting international media attention and positive feedback from participants [3]. - Since 2014, Tianjin University of Traditional Chinese Medicine has collaborated with a Russian medical institution to promote TCM therapies, drawing patients from SCO countries like Russia, Kazakhstan, and Uzbekistan to Tianjin for treatment [5]. - TCM is not only being practiced but also taught, with Tianjin University establishing long-term partnerships with universities in SCO countries to offer TCM-related courses and training programs [5]. Group 2: Educational Exchange and Cultural Dissemination - International students from SCO countries, such as Mongolia and Pakistan, are studying TCM in Tianjin, with many becoming cultural ambassadors for TCM upon returning to their home countries [7]. - Currently, there are 140 international students from SCO countries at Tianjin University, making up 28% of the total international student population, indicating a growing interest in TCM education [7]. - The increasing collaboration and exchange in TCM are expected to enhance health benefits for the populations of SCO member states [7].

Core Viewpoint - The internationalization of traditional Chinese medicine (TCM) has become a national strategy, with policies supporting its global expansion, creating a golden opportunity for the industry [1] Group 1: Successful Entry into Singapore - The first overseas market for the company, Singapore, has shown exceptional commercial results, validating the feasibility of its internationalization model [2] - By July 2025, revenue from Singapore stores increased by 119% year-on-year, demonstrating rapid growth in overseas performance [2] - The high customer retention rate indicates that the company's operational system is well-received in the overseas market, providing a replicable model for future global expansion [2] Group 2: Strategic Expansion Plans - Following the successful validation in Singapore, the company has outlined a strategic path focusing on "technology + products + store expansion" for international growth [3] - The company plans to focus on the Hong Kong market in 2025 and aims to expand its Singapore clinics to over 20 by the end of 2026 [3] Group 3: Technological Innovations - The company is addressing the shortage of TCM practitioners overseas by launching AI technology that encapsulates the clinical experience of top TCM experts [4] - The AI system has achieved over 86% consistency with expert simulations, enhancing the diagnostic capabilities of overseas TCM practitioners [4] - The establishment of a TCM heritage studio in Singapore aims to train and send skilled practitioners abroad, further improving service quality [4] Group 4: Product Development and Market Penetration - The successful certification and launch of the hair care product in Singapore marks a significant milestone in the company's product internationalization efforts [5] - The company has accumulated over 22 million patient records and 18 million structured medical records, enhancing the precision and safety of its product development [5] - The certification of the hair care product provides a reusable template for future product launches overseas [6] Group 5: Store Expansion Strategies - The company plans to adopt a mixed strategy for store expansion, combining self-built flagship stores, strategic partnerships, and acquisitions to enhance market penetration [6] - Self-built flagship stores will establish brand recognition and serve as a model for regional expansion [6] - Collaborations with local medical institutions will leverage existing customer bases, while acquisitions of quality clinics will create a differentiated competitive advantage [6] Group 6: Future Outlook - The company is moving towards becoming a global brand in TCM, with a closed-loop strategy of service expansion, cost reduction through technology, and profitability through product offerings [6] - The ongoing expansion into the Hong Kong market and the establishment of 20 clinics in Singapore are expected to solidify the company's position in the global TCM sector [6]

Core Viewpoint - Dongyangguang has been recognized as the "global pioneer in ecological breeding of Cordyceps" by Frost & Sullivan, affirming its leading position in the industry after 18 years of development in the Cordyceps sector [1] Group 1: Research and Development - The wild Cordyceps is primarily found in high-altitude areas (3500-5000 meters), and its production has significantly decreased due to overharvesting and climate change, leading to a resource crisis in the industry [3] - Dongyangguang initiated an ecological breeding program in 2007, investing over 4 billion yuan and employing more than 260 researchers to innovate across the entire industry chain [3] - The company has established a key laboratory for Cordyceps breeding and product research, recognized by the National Administration of Traditional Chinese Medicine [3] Group 2: Technological Innovation - The market for Cordyceps in China has surpassed 70 billion yuan, but challenges such as lack of industry standards and product quality inconsistencies hinder industry upgrades [6] - Dongyangguang has developed proprietary technologies to enhance product quality, ensuring that each batch of Cordyceps retains 2.7 times the SOD activity compared to traditional drying methods [6] - The company emphasizes quality control, achieving zero additives and significantly lower heavy metal content than regulatory limits [6] Group 3: Global Expansion - Dongyangguang is actively pursuing a global strategy while solidifying its domestic market presence, investing hundreds of millions in brand penetration [9] - The company has established over 350 brand stores in more than 150 cities, enhancing its reach to health-conscious consumers [12] - Dongyangguang is also expanding internationally, with plans for an overseas flagship store and participation in international forums to promote its brand [12][14]

Core Viewpoint - The conference on high-quality development of traditional Chinese medicine (TCM) highlighted the strategic layout of Guoshengtang in promoting the internationalization of TCM through "management empowerment + AI technology + products" to establish itself as the leading TCM health brand for the global Chinese community [1] Group 1: Management Expansion - Guoshengtang's acquisition of Singapore's Baozhongtang in March 2024 marks the beginning of its internationalization journey, achieving a revenue growth of 119% year-on-year by July 2025 [2] - The company plans to expand to 30 clinics in Singapore by the end of 2026, leveraging its mature domestic operational model [2] - Guoshengtang employs a multi-faceted strategy for overseas expansion, including self-built flagship stores, strategic partnerships with local TCM institutions, and acquisitions of quality Western medical clinics and hospitals [2] Group 2: AI Technology Deployment - The launch of 10 AI avatars of renowned TCM doctors addresses the shortage of quality TCM talent overseas, facilitating online follow-up consultations [4] - The AI avatars have achieved over 86% consistency in expert simulation, receiving high praise for their diagnostic accuracy and medication rationality [4][5] - The AI technology not only enhances domestic operations but also plays a crucial role in the company's international endeavors, breaking down barriers in the distribution of TCM talent [5] Group 3: Product Internationalization - Guoshengtang has made significant strides in the development of innovative TCM products, with its first self-developed TCM product receiving certification from Singapore's Health Sciences Authority [6] - The company is collaborating with Huaxi Hospital and Baidu to establish a clinical evaluation platform for TCM, aiming to address challenges in real-world data assessment [6] - Guoshengtang has accumulated extensive high-quality TCM data over 10 years, including over 17 million consultation records and 8 million medical records, which supports its innovative drug development efforts [6] Group 4: Future Outlook - The company aims to enhance its research and development of TCM formulations, creating a robust platform for innovative TCM services [7] - By integrating traditional TCM with modern technology, Guoshengtang is making significant progress towards its goal of becoming the global leading TCM brand for the Chinese community [7]